Vaccine maker stocks fall sharply after Trump names RFK Jr. as health secretary

Stocks of major vaccine manufacturers dropped sharply on Thursday after president-elect Donald Trump selected Robert F. Kennedy Jr. as the next health secretary. Moderna fell by six percent, while Pfizer and Novavax also experienced significant declines. Kennedy is known for his anti-vaccine stance and has previously spread misinformation about vaccine safety. He stated he would study vaccine efficacy but would not remove vaccines from public access. Vaccine companies have faced challenges due to reduced demand since the pandemic's peak. Pfizer and Moderna stocks have already seen substantial declines over the past year, reflecting ongoing struggles in the market.